Line up to six companies across valuation, growth, profitability, leverage, ownership and technicals. Best and worst per row are highlighted.
| Metric | UPL | SUMICHEM | BAYERCROP | SHARDACROP | DHANUKA |
|---|---|---|---|---|---|
| Size & Price | |||||
| Market capitalisation | ₹43,628 Cr | ₹20,842 Cr | ₹15,958 Cr | ₹6,397 Cr | ₹4,217 Cr |
| Enterprise value | ₹65,674 Cr | ₹20,844 Cr | — | ₹6,397 Cr | ₹4,259 Cr |
| Revenue (TTM) | ₹52,804 Cr | ₹3,245 Cr | ₹5,472 Cr | ₹5,357 Cr | ₹2,035 Cr |
| EBITDA (TTM) | ₹9,326 Cr | ₹685 Cr | ₹688 Cr | ₹1,047 Cr | ₹417 Cr |
| PAT (TTM) | ₹2,020 Cr | ₹579 Cr | ₹568 Cr | ₹626 Cr | ₹297 Cr |
| Current price | ₹516.80 | ₹417.60 | ₹3,554.20 | ₹709.20 | ₹935.05 |
| 1-day change | -4.25% | -3.61% | -2.02% | -1.98% | +0.72% |
| Avg volume (30d) | — | — | — | — | — |
| 52-week high | — | — | — | — | — |
| 52-week low | — | — | — | — | — |
| Distance from 52w high | — | — | — | — | — |
| Distance from 52w low | — | — | — | — | — |
| Valuation | |||||
| Price to earnings | 21.6× | 36.0× | 28.1× | 10.2× | 14.2× |
| Price to book | 1.3× | 6.1× | 5.4× | 2.0× | 3.0× |
| Price to sales | 0.8× | 6.4× | 2.9× | 1.2× | 2.1× |
| EV / EBITDA | 7.0× | 30.4× | — | 6.1× | 10.2× |
| Dividend yield | 1.16% | 0.6% | 5.21% | 2.12% | 0.43% |
| Earnings yield | 4.63% | 2.78% | 3.56% | 9.79% | 7.04% |
| PEG ratio | — | 13.65 | — | 0.4 | 1.14 |
| Book value / share | ₹410.6 | ₹67.9 | ₹660.5 | ₹347.6 | ₹311.0 |
| EPS (TTM) | ₹23.9 | ₹11.6 | ₹126.5 | ₹69.4 | ₹65.8 |
| Growth | |||||
| Sales growth (1y) | 11.2% | 2.9% | 3.7% | 21.9% | 15.7% |
| Sales growth (3y CAGR) | -1.1% | -2.7% | 3.4% | 9.2% | 11.3% |
| Sales growth (5y CAGR) | 6% | 4.1% | 5.9% | 17.1% | 12.7% |
| Profit growth (1y) | 114.3% | 7.4% | 21.3% | 123.7% | 24.2% |
| Profit growth (3y CAGR) | -18.6% | 2.6% | -3.1% | 25.8% | 12.4% |
| Profit growth (5y CAGR) | -7.7% | 9.5% | 6.9% | 24.3% | 16% |
| Qtr sales growth (YoY) | 10.5% | 0.6% | 32.2% | 9% | 20% |
| Qtr profit growth (YoY) | — | 20.4% | 49.3% | -38.4% | 27.9% |
| Profitability | |||||
| Operating margin | 17.9% | 20.7% | 15.4% | 20.4% | 20.5% |
| Net margin | 4.3% | 16.8% | 12.1% | 12.9% | 14.6% |
| Return on equity | 6% | 17.3% | 23.7% | 24.2% | 22.3% |
| Return on capital employed | 11.2% | 23.1% | 28.4% | 28% | 28.9% |
| Return on assets | 2.3% | 12.1% | 12.1% | 11.8% | 16.5% |
| ROE (3y avg) | 1.6% | 17.2% | 23.4% | 12.8% | 22% |
| ROCE (3y avg) | 7.9% | 22.8% | 28.4% | 15.2% | 28.2% |
| Leverage & Quality | |||||
| Debt to equity | 0.64 | 0 | — | 0 | 0.03 |
| Interest coverage | 2.0× | 96.0× | 44.2× | 487.1× | 77.7× |
| Current ratio | 1.21 | 3.44 | 1.92 | 1.86 | 3.3 |
| Working capital days | 135 | 155 | 300 | 125 | 160 |
| Ownership | |||||
| Promoter holding | 33.5% | 75% | 71.4% | 74.8% | 69.8% |
| Promoter pledge | 0% | 0% | 0% | 0% | 0% |
| FII holding | 43.7% | 3% | 4% | 3.1% | 1.6% |
| DII holding | 14.3% | 9.3% | 11.6% | 9.2% | 18.7% |
| Public holding | 8.4% | 12.7% | 13% | 12.9% | 9.8% |
| Promoter holding change (1y) | 0.01% | 0% | 0% | 0% | -0.06% |
| Technical | |||||
| 50-day moving average | — | — | — | — | — |
| 200-day moving average | — | — | — | — | — |
| Price vs 50 DMA | — | — | — | — | — |
| Price vs 200 DMA | — | — | — | — | — |
| RSI (14) | — | — | — | — | — |
| Return (1m) | — | — | — | — | — |
| Return (3m) | — | — | — | — | — |
| Return (6m) | — | — | — | — | — |
| Return (1y) | — | — | — | — | — |
| Return (3y CAGR) | — | — | — | — | — |
| Relative strength (1y) | — | — | — | — | — |
| Volatility (1y) | — | — | — | — | — |
| Beta | — | — | — | — | — |
best in row weakest in rowRows without a better/worse direction aren't highlighted.
| Line item | UPLMar 2022 · 2022-03-31Consolidated | SUMICHEMMar 2022 · 2022-03-31Consolidated | BAYERCROPMar 2022 · 2022-03-31Standalone | SHARDACROPMar 2022 · 2022-03-31Consolidated | DHANUKAMar 2022 · 2022-03-31Consolidated |
|---|---|---|---|---|---|
| Equity capital | 153 | 499 | 45 | 90 | 9 |
| Reserves | 21,522 | 1,428 | 2,479 | 1,822 | 951 |
| Minority interest | 7,633 | — | — | 0 | — |
| Borrowings | 25,866 | — | 0 | 38 | 1 |
| Other liabilities | 27,505 | 1,082 | 1,829 | 1,663 | 351 |
| Total equity & liabilities | 82,679 | 3,010 | 4,353 | 3,614 | 1,312 |
| Fixed assets | 35,401 | 354 | 441 | 14 | 159 |
| CWIP | 1,184 | 21 | 13 | — | 48 |
| Investments | 1,922 | 356 | 65 | — | 336 |
| Other assets | 44,172 | 2,278 | 3,834 | — | 769 |
| Total assets | 82,679 | 3,010 | 4,353 | 3,614 | 1,312 |
A blank means that line was not filed or cannot be derived for that company. Compare periods and basis labels before reading across a row.